Odile Prigneau
Chief Executive Officer at Prestizia SASU
Profile
Odile Prigneau is currently the Chief Executive Officer at Prestizia SASU since 2013.
Prior to this, she worked as the Director of Marketing and Business Development at Theradiag SA. She holds a doctorate degree from the Université de Paris 5 René Descartes.
Odile Prigneau active positions
Companies | Position | Start |
---|---|---|
Prestizia SASU
Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Part of Biosynex SA, Prestizia SASU is a French company that provides biotechnology research and development services. The company is based in Paris, France. Odile Prigneau has been the CEO of the company since 2013. Prestizia was acquired by Theradiag SA, a subsidiary of Biosynex SA from Truffle Capital SAS on June 27, 2012. | Chief Executive Officer | 18/09/2013 |
Former positions of Odile Prigneau
Companies | Position | End |
---|---|---|
THERADIAG | Corporate Officer/Principal | - |
Training of Odile Prigneau
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Theradiag SA
Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
Université de Paris 5 René Descartes | Consumer Services |
Prestizia SASU
Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Part of Biosynex SA, Prestizia SASU is a French company that provides biotechnology research and development services. The company is based in Paris, France. Odile Prigneau has been the CEO of the company since 2013. Prestizia was acquired by Theradiag SA, a subsidiary of Biosynex SA from Truffle Capital SAS on June 27, 2012. | Commercial Services |
- Stock Market
- Insiders
- Odile Prigneau